These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23420550)

  • 1. Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial.
    Montgomery SV; Barsevick AM; Egleston BL; Bingler R; Ruth K; Miller SM; Malick J; Cescon TP; Daly MB
    Fam Cancer; 2013 Sep; 12(3):537-46. PubMed ID: 23420550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives.
    Vos J; Menko F; Jansen AM; van Asperen CJ; Stiggelbout AM; Tibben A
    Fam Cancer; 2011 Mar; 10(1):87-96. PubMed ID: 20852944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.
    Wagner Costalas J; Itzen M; Malick J; Babb JS; Bove B; Godwin AK; Daly MB
    Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):11-8. PubMed ID: 12704633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships.
    McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
    Am J Med Genet A; 2005 Mar; 133A(2):165-9. PubMed ID: 15633195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Communication about positive BRCA1 and BRCA2 genetic test results and uptake of testing in relatives in a diverse Asian setting.
    Lee DS; Meiser B; Mariapun S; Hassan T; Yip CH; Mohd Taib NA; Teo SH; Thong MK; Yoon SY
    J Genet Couns; 2021 Jun; 30(3):720-729. PubMed ID: 33245177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Cancer Risk Perceptions among Relatives of Women with Uninformative Negative BRCA1/2 Test Results: The Moderating Effect of the Amount of Shared Information.
    Himes DO; Clayton MF; Donaldson GW; Ellington L; Buys SS; Kinney AY
    J Genet Couns; 2016 Apr; 25(2):258-69. PubMed ID: 26245632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial communication and cascade testing among relatives of BRCA population screening participants.
    Lieberman S; Lahad A; Tomer A; Koka S; BenUziyahu M; Raz A; Levy-Lahad E
    Genet Med; 2018 Nov; 20(11):1446-1454. PubMed ID: 29595811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facilitated cascade testing (FaCT): a randomized controlled trial.
    Nitecki R; Moss HA; Watson CH; Urbauer DL; Melamed A; Lu KH; Lipkin SM; Offit K; Rauh-Hain JA; Frey MK
    Int J Gynecol Cancer; 2021 May; 31(5):779-783. PubMed ID: 33443030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Communicating genetic test results within the family: Is it lost in translation? A survey of relatives in the randomized six-step study.
    Daly MB; Montgomery S; Bingler R; Ruth K
    Fam Cancer; 2016 Oct; 15(4):697-706. PubMed ID: 26897130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations.
    Ratnayake P; Wakefield CE; Meiser B; Suthers G; Price MA; Duffy J; ; Tucker K
    Fam Cancer; 2011 Mar; 10(1):97-105. PubMed ID: 20878485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intention to communicate BRCA1/BRCA2 genetic test results to the family.
    Barsevick AM; Montgomery SV; Ruth K; Ross EA; Egleston BL; Bingler R; Malick J; Miller SM; Cescon TP; Daly MB
    J Fam Psychol; 2008 Apr; 22(2):303-12. PubMed ID: 18410217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
    Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
    Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
    McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
    Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2.
    Adams I; Christopher J; Williams KP; Sheppard VB
    J Cancer Educ; 2015 Jun; 30(2):344-52. PubMed ID: 25301325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences of BRCA1/2 Gene Mutation-Positive Women With Cancer in Communicating Genetic Risk to Their Relatives.
    Seven M; Shah LL; Daack-Hirsch S; Yazici H
    Cancer Nurs; 2021 May-Jun 01; 44(3):E142-E150. PubMed ID: 32022782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Men with metastatic prostate cancer carrying a pathogenic germline variant in breast cancer genes: disclosure of genetic test results to relatives.
    Vlaming M; Ausems MGEM; Schijven G; van Oort IM; Kets CM; Komdeur FL; van der Kolk LE; Oldenburg RA; Sijmons RH; Kiemeney LALM; Bleiker EMA
    Fam Cancer; 2024 Jun; 23(2):165-175. PubMed ID: 38722431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results.
    Hughes C; Lerman C; Schwartz M; Peshkin BN; Wenzel L; Narod S; Corio C; Tercyak KP; Hanna D; Isaacs C; Main D
    Am J Med Genet; 2002 Jan; 107(2):143-50. PubMed ID: 11807889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.
    Bakos AD; Hutson SP; Loud JT; Peters JA; Giusti RM; Greene MH
    Health Expect; 2008 Sep; 11(3):220-31. PubMed ID: 18816319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: a qualitative study of patient preferences.
    Hurley K; Rubin LR; Werner-Lin A; Sagi M; Kemel Y; Stern R; Phillips A; Cholst I; Kauff N; Offit K
    Cancer; 2012 Dec; 118(24):6270-7. PubMed ID: 22736296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Communicating genetic test results to the family: a six-step, skills-building strategy.
    Daly MB; Barsevick A; Miller SM; Buckman R; Costalas J; Montgomery S; Bingler R
    Fam Community Health; 2001 Oct; 24(3):13-26. PubMed ID: 11563941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.